Cargando…

Metabolic Reprogramming and Vulnerabilities in Cancer

Metabolic programs are rewired in tumors to support growth, progression, and immune evasion. A wealth of work in the past decade has delineated how these metabolic rearrangements are facilitated by signaling pathways downstream of oncogene activation and tumor suppressor loss. More recently, this fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyssiotis, Costas A., Nagrath, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016671/
https://www.ncbi.nlm.nih.gov/pubmed/31905922
http://dx.doi.org/10.3390/cancers12010090
_version_ 1783497028692606976
author Lyssiotis, Costas A.
Nagrath, Deepak
author_facet Lyssiotis, Costas A.
Nagrath, Deepak
author_sort Lyssiotis, Costas A.
collection PubMed
description Metabolic programs are rewired in tumors to support growth, progression, and immune evasion. A wealth of work in the past decade has delineated how these metabolic rearrangements are facilitated by signaling pathways downstream of oncogene activation and tumor suppressor loss. More recently, this field has expanded to include metabolic interactions among the diverse cell types that exist within a tumor and how this impacts the immune system. In this special issue, 17 review articles discuss these phenomena, and, alongside four original research manuscripts, the vulnerabilities associated with deregulated metabolic programming are highlighted and examined.
format Online
Article
Text
id pubmed-7016671
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70166712020-02-28 Metabolic Reprogramming and Vulnerabilities in Cancer Lyssiotis, Costas A. Nagrath, Deepak Cancers (Basel) Editorial Metabolic programs are rewired in tumors to support growth, progression, and immune evasion. A wealth of work in the past decade has delineated how these metabolic rearrangements are facilitated by signaling pathways downstream of oncogene activation and tumor suppressor loss. More recently, this field has expanded to include metabolic interactions among the diverse cell types that exist within a tumor and how this impacts the immune system. In this special issue, 17 review articles discuss these phenomena, and, alongside four original research manuscripts, the vulnerabilities associated with deregulated metabolic programming are highlighted and examined. MDPI 2019-12-30 /pmc/articles/PMC7016671/ /pubmed/31905922 http://dx.doi.org/10.3390/cancers12010090 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Lyssiotis, Costas A.
Nagrath, Deepak
Metabolic Reprogramming and Vulnerabilities in Cancer
title Metabolic Reprogramming and Vulnerabilities in Cancer
title_full Metabolic Reprogramming and Vulnerabilities in Cancer
title_fullStr Metabolic Reprogramming and Vulnerabilities in Cancer
title_full_unstemmed Metabolic Reprogramming and Vulnerabilities in Cancer
title_short Metabolic Reprogramming and Vulnerabilities in Cancer
title_sort metabolic reprogramming and vulnerabilities in cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016671/
https://www.ncbi.nlm.nih.gov/pubmed/31905922
http://dx.doi.org/10.3390/cancers12010090
work_keys_str_mv AT lyssiotiscostasa metabolicreprogrammingandvulnerabilitiesincancer
AT nagrathdeepak metabolicreprogrammingandvulnerabilitiesincancer